Simulations are a practical and reliable approach to power calculations, especially for multi-level mixed effects models where the analytic solutions can be very complex. In addition, power calculations are model-specific and multi-level mixed effects models are defined by a plethora of parameters. In other words, model variations in this context are numerous and so are the tailored algebraic calculations. This article describes ipdpower in Stata, a new simulations-based command that calculates power for mixed effects two-level data structures. Although the command was developed having individual patient data meta-analyses and primary care databases analyses in mind, where patients are nested within studies and general practices respectively, the methods apply to any two-level structure.
Introduction
The size of primary care databases (PCDs) allows for investigations that cannot normally be undertaken in much smaller randomised controlled trials (RCTs), such as the moderating effect of a patient characteristic on the effect of an intervention. However, researchers quite often underestimate the numbers needed to detect such effects and assume that the size of the database alone guarantees adequate power for any type of investigation. The essential structure of a PCD dataset closely resembles that of an individual patient data (IPD) metaanalysis, with patients nested (clustered) in general practices in the former and in studies in the latter, thus the same modelling approaches and power analysis considerations are applicable to both. In individual patient data meta-analyses, the quantity of the collected data from numerous RCTs sometimes deceives researchers with regards to the power in their analysis and can lead to the assumption that a power calculation is not necessary. However, even though power calculations are quite often needed in these contexts, especially for detecting a moderating effect, available software options are not user friendly or can only cope with simple models (e.g., without random effects for the higher level clusters). Hence, it is not uncommon for researchers to use a rough 'four-times as many patients needed as for the main effect' over-simplification to estimate power (McClelland and Judd 1993) .
More recently, an algebraic approximation approach, which uses study summary statistics, was developed by Kovalchik and Cumberland (2012) and implemented in R (Kovalchik 2013 ; R Development Core Team 2013) for individual patient data meta-analysis. Overall, Kovalchik and Cumberland found that their computationally cheap method performed well in simulations although it is constrained by distributional assumptions and performance deteriorated in some scenarios. Although this approach can be very useful, it is limited to a randomised controlled trial setting with a binary treatment, a patient-level covariate and a binary or continuous outcome. In addition, random effects for the intercept and intervention were modelled but other random effects (e.g., for the covariate) were not considered.
Using simulations to calculate power is a well-known but computationally expensive approach (Feiveson 2002) , but with the availability of powerful computers, simulations can be a very useful alternative when it comes to complex study designs for which power equations are unavailable or prohibitively complex (Arnold, Hogan, Colford, and Hubbard 2011) . The ipdpower command for Stata (StataCorp. 2011) provides a simple but flexible framework for simulation-based power calculations. Various random effects at the cluster (e.g., practice, study) level can be hypothesised, the outcome can be continuous, binary or count data, covariates and moderators (i.e., interactions) can be modelled at the cluster-or patient-level, exposure can be binary (e.g., intervention) or continuous (as is often the case in observational studies) and distributions for the random effects and continuous variables can be simulated to be non-normal. Besides power, the command provides additional information that can be useful when designing a study, for example coverage (type I error) which might depart from the nominal level when the data structure is complex.
Methods
The command proceeds in two steps, within each simulation iteration. First, it generates a dataset, defining the outcome according to the specified coefficients for the intercept (constant), the exposure (intervention), the covariate and the exposure-covariate interaction (moderator effect). Second, it uses regression modelling to calculate model fit statistics, power and coverage for the dataset. Information is then aggregated across all simulated datasets. Power indicates the percentage of iterations in which a model coefficient was found to be statistically significant and in the hypothesised direction. Coverage indicates the percentage of confidence intervals around the coefficient that include the true value and should correspond to the hypothesised α level. Binomial proportion confidence intervals using the cii command are calculated for both power and coverage.
Dataset generation
For a continuous outcome, each dataset is generated using the following set of equations:
and when assuming a normal distribution for the error and random effects
where i the patient j the the cluster (e.g., study) Y ij the outcome for patient i in cluster j group ij exposure for patient i in cluster j X ij the covariate (e.g., baseline level) for patient i in cluster j group ij * X ij the exposure-covariate interaction (moderator) for patient i in cluster j β 0j the intercept for cluster j γ 0 the mean common intercept β 1j the exposure effect for cluster j γ 1 the mean exposure effect β 2j the covariate effect for cluster j γ 2 the mean covariate effect β 3j the interaction effect for cluster j γ 3 the mean interaction effect u 0j the random intercept for cluster j u 1j the random exposure effect for cluster j u 2j the random covariate effect for cluster j u 3j the random interaction effect for cluster j τ 0 2 the between-cluster variance for the intercept τ 1 2 the between-cluster variance for the exposure effect τ 2 2 the between-cluster variance for the covariate effect τ 3 2 the between-cluster variance for the interaction effect ij the error term for patient i in cluster j σ 2 j the within-cluster variance for cluster j If the outcome is dichotomous equation (1a) becomes:
where p ij the probability that the outcome is 1 for patient i in cluster j and coefficients now correspond to log odds (β 0 ) and log odds ratios (β 1 ,β 2 and β 3 ).
And for a count outcome, equation (1a) becomes:
where E(Y ij ) the expectation of Y ij and the coefficients correspond to log incidence (β 0 ) and log incidence rates(β 1 ,β 2 and β 3 ).
However, we also implemented two alternative skew-normal distributions for the random effects and residual error using methods described by Ramberg, Dudewicz, Tadikamalla, and Mykytka (1979) . Besides normal distributions (skewness=0; kurtosis=3), ipdpower can model moderate-skew (skewness=1; kurtosis=4) and extreme-skew (skewness=2; kurtosis=9) distributions with the same means and variances as described in equation (3). Although non-normal distributions for the random effects have not been found to notably affect the performance of two-stage meta-analysis methods (Kontopantelis and Reeves 2012) , deviations from normality are not necessarily insignificant in this context.
ipdpower allows various random effects components (intercept, exposure, covariate and interaction) to be incorporated in each dataset. In meta-analysis nomenclature, the variance associated with random effects is described as heterogeneity of the exposure (treatment) effect in two-stage meta-analyses (stage 1: obtain or calculate study results; stage 2: calculate overall effect using an appropriate method). When individual patient data are available, meta-analysts can choose one of many mixed effects regression models to combine information and model various random effects in a single stage , which is considered the best approach to meta-analysis (Mathew and Nordstrom 2010) . Usually heterogeneity is quantified with I 2 (Higgins and Thompson 2002) or H 2 (Mittlbock and Heinzl 2006) , using the within (σ 2 ) and between-study (τ 1 2 ) variance estimates (assuming within-variance is similar across clusters). Since the error (defined using variance σ 2 j ) is only meaningful in OLS regressions, these heterogeneity measures are only relevant when the outcome is continuous in IPD meta-analysis (in Stata, σ 2 j is fixed to π 2 /3 for logistic regressions). For this reason ipdpower accepts between-cluster variance inputs (τ 0 2 , τ 1 2 , τ 2 2 and τ 3 2 ) to define the random effects for each cluster. However, when the outcome is continuous and users wish to utilise I 2 as a starting point to define model heterogeneity, solving for τ 2 returns (Higgins and Thompson 2002) :
Similarly, τ i 2 = (H i 2 − 1)σ 2 , where i ∈ {0, 1, 2, 3}, and the command also provides I 2 and H 2 as outputs for users to double-check their calculations.
Regression modelling
ipdpower provides seven different regression modelling options, consistent across the three possible outcome types, to account for the various levels of complexity in the generated datasets. The simplest analysis approach, model(1), does not account for clustering, assumes no random effects and employs commands regress, logit or poisson for continuous, binary or count outcomes respectively. A more advanced approach (model (2)), declares the data as clustered using xtset and analyses with xtreg, xtlogit or xtpoisson. With this family of models only a random effects component for the intercept (τ 0 2 > 0) is considered and estimated. More advanced modelling options, which allow consideration of more random effects components, have also been implemented. However, these models which use xtmixed, xtmelogit and xtmepoisson (renamed in Stata v13), can be computationally expensive and do not always converge. These modelling approaches have been described in the IPD metaanalysis context (Higgins, Whitehead, Turner, Omar, and Thompson 2001; Turner, Omar, Yang, Goldstein, and Thompson 2000; Whitehead 2002; . The simplest of them, model(3), assumes a fixed common intercept, random exposure effects (τ 1 2 > 0) and fixed effect for the covariate. The recommended model for meta-analyses (Whitehead 2002) , model(4), assumes fixed study specific intercepts, random exposure effects (τ 1 2 > 0) and fixed study specific effects for the covariate. model(5) assumes random study intercepts (τ 0 2 > 0), random exposure effects (τ 1 2 > 0) and fixed study specific effect for the covariate. model(6) assumes random study intercepts (τ 0 2 > 0), random exposure effects (τ 1 2 > 0) and random effects for the covariate (τ 2 2 > 0). model(7) assumes random study intercepts (τ 0 2 > 0), random exposure effects (τ 1 2 > 0), random effects for the covariate (τ 2 2 > 0) and random effects for the interaction (τ 3 2 > 0). The more complicated the model the more likely analysis will fail to converge in a particular dataset, and this is often the case for the last three models -especially the last one.
Although fixed effect models are widely used in two-stage meta-analyses, even when heterogeneity is not zero (Kontopantelis, Springate, and Reeves 2013) , accounting for even low levels of between-cluster variability is a more conservative approach (Hunter and Schmidt 2000) . When a fixed effects model is incorrectly assumed, both coverage and power deteriorate as true heterogeneity increases (Brockwell and Gordon 2001; Kontopantelis and Reeves 2012) . Analogously, for patient data analyses, we would expect poor fit from model(1), the fixed effect approach, in the presence of heterogeneity. More generally, the closer the modelling assumptions to the true data structure, the better the expected performance. However, as explained previously, the more complex models come with practical limitations so users must make the choice that best suits their needs in this trade-off between feasibility and model correctness. From this point of view, the usability of ipdpower is not limited to power calculations for a moderator effect, but it can be used to evaluate the overall performance of current modelling approaches in various simulated scenarios. For example, to compare model(4), the preferred IPD meta-analysis approach, to the simpler model(3).
3. The ipdpower command 3.1. Syntax
Number (integer ) of simulations to execute. At least 1000 are recommended for relatively narrow confidence intervals.
ssl(#) Total number (integer ) of patients across all higher level units (clusters).
ssh(#) Number (integer ) of higher level units (e.g., studies, general practices etc).
b0(#) Coefficient (real ) for the intercept (constant) of regression model. For logistic and
Poisson regression log odds and log incidence rates are expected respectively. The coefficient can be zero.
b1(#) Coefficient (real ) for the exposure variable (e.g., intervention: treatment vs no treatment) of the regression model. For logistic and Poisson regression log odds ratios and log incidence rate ratios are expected respectively. The coefficient can be zero.
b2(#) Coefficient (real ) for the covariate variable (e.g., age) of the regression model. It can be continuous (default) or binary (bcov option), and patient-level (default) or study-level (slcov option). For logistic and Poisson regression log odds ratios and log incidence rate ratios are expected respectively. The coefficient can be zero. Note that the covariate, when continuous, is always assumed to be standardised (mean=0 and sd=1) since interactions are included in the models. Users need to take that into consideration when deciding on b2.
b3(#) Coefficient (real ) for the exposure-covariate interaction variable. The command can automatically handle a binary by continuous, binary by binary or continuous by continuous interaction term. For logistic and Poisson regression log odds ratios and log incidence rate ratios are expected respectively. The coefficient can be zero. Note that the covariate, when continuous, is always assumed to be standardised (mean=0 and sd=1) to allow for meaningful estimates. Users need to take that into consideration when deciding on b3.
Optional
Data Structure minsh(#) Minimum mumber (integer ) of patients in a higher level unit. The default is 50 since this is usually the threshold above which the effort required to obtain individual patient data for meta-analysis is justified. The command uses the numbers provided with ssl(#), ssh(#) and minsh(#) to draw sizes for the higher level units from a uniform distribution. If the average size for the higher level unit is smaller than the minimum number of patients the command will return an error.
hpoisson Inform the command that the higher level unit sizes will not be drawn from a uniform but a Poisson distribution with mean=ssl(#)/ssh(#). This approach provides cluster sizes that are much more similar in size. Cannot be used with option minsh(#).
icluster Inform the command that the exposure is clustered at the higher level units (e.g., cluster-RCT). Can only be selected when exposure is binary and with balanced designs (i.e., cannot be used with cexp or cb(#)). Clusters assigned an odd identifier are assumed to include controls and clusters assigned even identifiers are assumed to include the intervention cases (i.e., if an odd number of higher level units is simulated with icluster there will be an additional cluster of controls).
outc(#) Type of outcome: 0=continuous (default); 1=dichotomous; 2=count. The model for a continuous outcome is y = b0 + b1 * grp + b2 * xcovar + b3 * xcovar * grp + u0 + u1 * grp + u2 * xcovar + u3 * xcovar * grp + errx, where grp the exposure variable, xcovar the covariate, xcovar*grp their interaction, u0-u3 the random effects components and errx the residual errors. For a binary outcome the model is y = unif orm()<invlogit(b0 + b1 * grp + b2 * xcovar + b3 * xcovar * grp + u0 + u1 * grp + u2 * xcovar + u3 * xcovar * grp) and for a count outcome it is y = rpoisson(exp(b0 + b1 * grp + b2 * xcovar + b3 * xcovar * grp + u0 + u1 * grp + u2 * xcovar + u3 * xcovar * grp)). Negative binomial models were considered as an alternative for count data but they were thought to be too complex to be of much practical use in the assumption-laden context of power calculations. Note that residual errors can only be directly controlled in the OLS regression model. cb(#) Probability (real ) for patient membership to the exposure group (grp=1), when exposure is binary. The default is 0.5 for a balanced design.
cexp Inform the command that exposure is continuous (standardised, i.e., mean=0 and sd=1) rather than binary (the default).
cexpd(#) Distribution for continuous exposure: 0=normal; 1=moderate skew; 2=extreme skew. Normal distribution for the exposure (skew=0, kurtotis=3) is the default. Moderate (skew=1, kurtotis=4) and extreme skewness (skew=2, kurtotis=9) are implemented using Ramberg et al. (1979) method. The distribution for the exposure will not affect the distribution of the outcome much unless b1 is reasonably large. Note that the exposure, when continuous, is always assumed to be standardised (mean=0 and sd=1) since interactions are included in the models. Users need to take that into consideration when deciding on b1 and b3.
errsd(#) For continuous outcome only, standard deviation for the residual error (real ). The default is 1. This value, combined with the model coefficients, will affect the model fit; e.g., a large value will drive down the average adjusted R 2 . It also affects model heterogeneity since this is effectively the sd for the outcome within the higher level unit (e.g., within-study variability).
sderrsd(#) For continuous outcome only, standard deviation for the standard deviation of the residual error (real ). In other words, it allows the residual error to vary across higherlevel units, which might be a more realistic modelling strategy. The default is 0, not allowing variation which complies with modelling and heterogeneity assumptions (e.g., pooled withinvariance is used for heterogeneity calculations).
derr(#) For continuous outcome only, distribution for errors and hence outcome: 0=normal; 1=moderate skew; 2=extreme skew. Normal distribution for the error (skew=0, kurtotis=3) is the default. Moderate (skew=1, kurtotis=4) and extreme skewness (skew=2, kurtotis=9) are implemented using Ramberg et al. (1979) method. The distribution for the errors will affect the distribution of the outcome and the larger the modelled errors the more similar the two distributions.
ccovd(#) Distribution for continuous covariate: 0=normal; 1=moderate skew; 2=extreme skew. Normal distribution for the covariate (skew=0, kurtotis=3) is the default. Moderate (skew=1, kurtotis=4) and extreme skewness (skew=2, kurtotis=9) are implemented using Ramberg et al. (1979) method. The distribution for the covariate will not affect the distribution of the outcome much unless b2 is reasonably large. Note that the covariate, when continuous, is always assumed to be standardised (mean=0 and sd=1) since interactions are included in the models. Users need to take that into consideration when deciding on b2 and b3.
bcov Inform the command that the covariate is binary covariate instead of continuous (the default).
bcb(#) For binary covariate only, probability (real ) that xcovar=1. The default is 0.5.
slcov Inform the command that the covariate is higher-level (e.g., study-level: recruitment setting) rather than patient-level(the default).
Random effects tsq0(#) Random effect between higher level variance for the intercept. The default value is 0, which assumes homogeneity and no random effects. Heterogeneity for this model factor (intercept) is calculated using tsq0 and errsd. For example I 2 = 100 * tausq0/(tausq0 + errsd 2 ) and H 2 = 1/(1 − tausq0/(tausq0 + errsd 2 )). Solving for tausq0 we obtain tausq0 = (I 2 * errsd 2 )/(100 − I 2 ) and tausq0 = H 2 * errsd 2 − errsd 2 . Although ipdpower does not allow I 2 or H 2 inputs for the random effects components, they can be easily calculated using these formulas. Additionally users can use the di option to obtain the hypothesised heterogeneity levels for the inputted within-and between-variance parameters (say in a small trial simulation, if unsure of calculations).
tsq1(#)
Random effect between higher level variance for the exposure. The default value is 0, which assumes homogeneity and no random effects. Heterogeneity for this model factor (exposure) would be calculated using tsq1 and errsd. See tsq0(#) for calculation details.
tsq2(#) Random effect between higher level variance for the covariate. The default value is 0, which assumes homogeneity and no random effects. Heterogeneity for this model factor (covariate) would be calculated using tsq2 and errsd. See tsq0(#) for calculation details.
tsq3(#) Random effect between higher level variance for the exposure*covariate interaction term. The default value is 0, which assumes homogeneity and no random effects. Heterogeneity for this model factor (interaction) would be calculated using tsq3 and errsd. See tsq0(#) for calculation details.
dtp0(#) Distribution for intercept random effect: 0=normal; 1=moderate skew; 2=extreme skew. Normal distribution (skew=0, kurtotis=3) is the default. Moderate (skew=1, kurtotis=4) and extreme skewness (skew=2, kurtotis=9) are implemented using the Ramberg et al. (1979) method. In the standard two-stage meta-analysis setting, a non-normal distribution for the random effects has been found to have a small effect on power and coverage -even when the distribution is quite extreme. dtp1(#) Distribution for exposure random effect: 0=normal (default, skew=0, kurtosis=3); 1=moderate skew (skew=1, kurtosis=4); 2=extreme skew (skew=2, kurtosis=9).
dtp2(#) Distribution for covariate random effect: 0=normal (default, skew=0, kurtosis=3); 1=moderate skew (skew=1, kurtosis=4); 2=extreme skew (skew=2, kurtosis=9).
dtp3(#) Distribution for exposure*covariate interaction random effect: 0=normal (default, skew=0, kurtosis=3); 1=moderate skew (skew=1, kurtosis=4); 2=extreme skew (skew=2, kurtosis=9).
covmat(name ) Covariance matrix for normally distributed random effects. Alternative random effects definition to allow modelling of relationships between the random effects components. The matrix needs to be a 4x4 symmetrical non-negative matrix, with the diagonal elements corresponding to the random effects variances for intercept (name[1,1]), exposure (name[2,2]), covariate (name [3, 3] ) and interaction (name [4, 4] ). Non-normal random effects cannot be modelled using this approach.
Missing data missp(#) Probability (real ) that outcome is missing, to allow for missing data mechanisms. If option mar(#) is defined, data are assumed to be missing under a missing at random (MAR) mechanism. If option mnar(#) is defined, data are assumed to be missing under a missing not at random (MNAR) mechanism. If neither mar(#) or mnar(#) are provided along with missp(#), data are assumed to be missing under a missing completely at random (MCAR) mechanism.
mar(#)
Odds ratio (real ) that defines a missing at random (MAR) mechanism. The relationship between the covariate and missingness in the outcome is defined by z=ln(mar(#))*xcovar (i.e a logistic regression model), and the missing data are selected (i.e., set to missing) from the z=1 sub-sample. So a value of 1 implies the mechanism is MCAR, a value above 1 implies that the outcome is more likely to be missing for larger values of the covariate and a value below 1 implies that the outcome is more likely to be missing for smaller values of the covariate.
mnar(#)
Odds ratio (real ) that defines a missing not at random (MNAR) mechanism. The relationship between the outcome and missingness in the outcome is defined by z=ln(mnar(#))*y (i.e a logistic regression model), and the missing data are selected (i.e., set to missing) from the z=1 sub-sample. So a value of 1 implies the mechanism is MCAR, a value above 1 implies that the outcome is more likely to be missing for larger values of the outcome and a value below 1 implies that the outcome is more likely to be missing for smaller values of the outcome.
minum(#) Number (integer > 1) of multiple imputations to be executed. This options informs ipdpower that multiple-imputation models will be used and therefore missing data with one of the three available structures (MCAR, MAR, MNAR) need to have been defined. For the imputations, univariate linear, logistic or Poisson regression is used depending on the outcome (see mi impute). The imputed datasets are then analysed using mi estimate as a prefix, for the seven available models. Note that this process can be time consuming for complex models and binary or count outcomes, while convergence issues are amplified since all imputed datasets must run successfully for mi estimate to return results. Therefore 5 imputations are recommended for most models, and 2-3 for non-continuous outcomes and models 5, 6 or 7 (see model(#) below).
mipmm(#)
For a continuous outcome, it informs that missing data will be imputed using a predictive mean matching algorithm (rather than linear regression). The algorithm is computationally more expensive and # defines the number (integer ≥ 1) of closest observations (nearest neighbors) to draw from.
Modelling model(#) Specifies the form of the regression model: 1 simple, 2 random effects for intercept, 3-7 various mixed effects options. Model 1 corresponds to a regression with regress, logit or poisson, for continuous, binary and count outcomes respectively. Random effects are not considered at all under these models. Model 2 uses the xt family of models, sets the higher level as a panel variable with xtset and analyses with xtreg, xtlogit or xtpoisson.Only a random effects component for the intercept is considered under with this set of models. Models 3-7 allow for more advanced modelling options, accounting for various random effect components, but are computationally expensive and do not always converge (using xtmixed, xtmelogit and xtmepoisson which have been renamed in Stata v13 -but we wished to ensure ipdpower was compatible with Stata v12). The modelling approaches have been described for ipdforest and in the following descriptions we assume the highel level is study (i.e., patients nested within studies), for convenience. Model 3 assumes a fixed common intercept, random exposure effects and fixed effect for the covariate. Model 4 assumes fixed study specific intercepts, random exposure effects and fixed study specific effect for the covariate (which is usually the recommended model for performing individual patient data meta-analysis). Model 5 assumes random study intercepts, random exposure effects and fixed study specific effect for the covariate. Model 6 assumes random study intercepts, random exposure effects and random effects for the covariate. Model 7 assumes random study intercept, random exposure effects, random effects for the covariate and random effects for the interaction. Models 5 and 6 often fail to converge and for model 7 non-convergence is more frequent than convergence.
clvl(#) Set confidence level. The default is 95% (alpha level of 5%). See level.
seed(#) Set initial value of random-number seed, for the simulations. The default is 7. See set seed.
nskip Add noskip option to xtlogit or xtpoisson to return McFadden's pseudo R 2 . This option is only relevant when model(2) with outc(1) or outc(2) is used. Computationally, this approach is more expensive since it additionally fits a full maximum-likelihood model with only a constant for the regression equation be fit (which is used as the base model for the comparison with the final model).
dnorm Add normal option to xtpoisson to assume normally distributed random effects for the intercept. The default is gamma-distributed which is computationally less expensive. Additionally, when the normal option is specified, model convergence often fails. This option is only relevant when model(2) with outc(2). A skew-normal distribution is similar to gamma and perhaps skew-normal random effects should be considered when modelling count data.
xnodts Suppress simulation progress display. If option not specified, a '.' is displayed for each successful model run (i.e., converging) and an 'x' for each unsuccessful iteration.
di Display results at the end of the simulation process, including: simulation characteristics, average model fit, average statistics for the outcome, average b0-b3, hypothesised heterogeneity values, power and coverage.
moreon Set more on (default is off).
Saved results
ipdpower saves the following scalar results in r(): Coefficient estimates, power, coverage, simulations and computational time information is always returned. An R 2 statistic cannot be returned for the more advanced multi-level models with xtmixed, xtmelogit or xtmepoisson or for multiple imputations. With model(1), the average adjusted R 2 is returned from regress and the average pseudo R 2 from logit or poisson. With model(2), the average overall R 2 is returned from xtreg and, if the nskip option is specified, the average overall McFadden's pseudo R 2 from xtlogit or xtpoisson. Within-sd is only reported for continuous outcomes and when data are analysed with xtreg or xtmixed. The between-sd components are only returned if accounted for and estimated by the specified model.
Example
As an example, we used ipdpower to calculate the power in a few designs where the outcome is continuous. First we assumed 20 clusters, a total of 5000 patients, no random effects and the default level for the residual error (σ = 1). The generated outcome for the model could be described by Y ij = 1 + 0.5group ij + 0.3X ij + 0.1group ij * X ij + ij and we proceeded to analyse using option model(2), i.e., xtreg allowing for a random intercept.
. ipdpower, sn(1000) ssl (5000) ssh (20) b0 (1) 1.050 mean(grp=1):
1.488 sd(grp=1):
1.044 modelled within-study variance pooled: 1.000 modelled between-study variance (tau^2) exposure: 0.000 covariate:
0.000 interaction:
0.000 intercept:
0.000 modelled heterogeneity, I^2 (range: 0 to 100%) exposure: 0.00 covariate:
0.00 interaction:
0.00 intercept:
0.00 modelled heterogeneity, H^2 (range: 1 to +inf) exposure: 1.00 covariate:
1.00 interaction:
1.00 intercept:
1.00 mean estimates b1 (exposure): 0.500 b2 (covariate):
0.300 b3 ( Modelled heterogeneity, modelled within-and between-cluster variances, the number of successful runs and computational time are always provided as outputs. On average, the model explained approximately 15.8% of the variance and performed well in the parameter estimation. Assuming we are interested in capturing the hypothesised interaction effect, the power to detect it was estimated at 93.6%. Coverage for the interaction effect was slightly below nominal at 93.7%. In the next step we introduce heterogeneity for the exposure.
. ipdpower, sn(1000) ssl (5000) ssh (20) b0 (1) 100.0(99.6-100.0)
The modelled heterogeneity was moderate, with I 2 = 33.3%. On average, the model explained less of the variance in the outcome, approximately 13.7%. The model betas and the residual error (within-sd) were estimated accurately on average but the model assumes a random intercept and underestimates the hypothesised heterogeneity (since the selected modelling approach assumes a random intercept, when a random exposure effect exists in the simulated data). The power to detect the interaction was slightly lower, estimated at 92.6% but coverage was excellent at 95.5%. However, notice the very low coverage for the exposure which was due to the introduced heterogeneity for that factor. Next, we change the distribution for the errors from normal to extreme skew-normal.
. ipdpower, sn (1000) ssl (5000) ssh (20) b0 (1) Although the non-normal errors did not appear to affect the model fit, power and coverage were slightly affected. The power to detect the interaction was 91.4% and coverage dropped to 92.9%. Coverage was still very problematic for the exposure. Next, we proceeded to analyse with a more appropriate model (model(3)), one that accounts for the exposure heterogeneity.
. ipdpower, sn (1000) ssl (5000) ssh (20) b0 (1) The model performed well and slightly under-estimated the hypothesised heterogeneity ( √ 0.5 ≈ 0.707). The power to detect the interaction was 93.4% and coverage was 94.3%. As expected, coverage for the exposure was not an issue for this model, since it is a much more accurate reflection of the hypothesised data structure. Finally, we analysed the data with the recommended model for IPD meta-analyses which is computationally more expensive (model(4)). Under this model, fixed cluster specific effects for the covariate and fixed cluster specific intercepts were assumed (i.e., different parameter estimates for each cluster) and therefore covariate and intercept information could not be reported.
. ipdpower, sn(1000) ssl(5000) ssh (20) b0(1) b1(0.5) b2(0.3) b3(0.1) tsq1(0.5) > model(4) derr (2) The model did not appear to perform better than model(3). The average heterogeneity estimate was similar and so were power and coverage for the interaction at 93.2% and 93.8% respectively. However, a more thorough investigation would be required to make a convincing recommendation on model choice.
Discussion
We aimed to describe ipdpower, a new simulation-based power calculation command. The command offers a plethora of modelling choices for researchers and its novelty lies with nonnormal distribution options and the various random effects assumptions that can be implemented. However, ipdpower is flexible and, at its simplest, the higher-level inputs can be ignored to produce power calculation of a one-level model. In addition, if a parameter is not needed (say the covariate or the interaction) the user can just set the respective coefficient to zero when defining the model structure.
Usually researchers wish to input the desired power level and estimate the number of patients and second level units required. Such an approach would be more complicated to implement in ipdpower since the parameters of interest are two (number of patients and number of higher-level units) and the combinations that would provide the desired power are many, unless one of them is fixed. Nevertheless, users with a little programming experience should call the command from a binary search algorithm (since power is a monotonic function of sample size), that dichotomises the search area to arrive to the solution quickly, in order to calculate the sample sizes needed to have a desired power level (Cormen, Leiserson, Rivest, Stein et al. 2001) . Either the average number of patients in a cluster or the number of clusters should be fixed in this approach. Similarly, researchers interested in generating datasets with the specified characteristics, rather than calculating power, can easily obtain them by taking advantage of the fact that ipdpower keeps the last simulated dataset in memory. Calling ipdpower from within a loop, with sim(1) and a different seed number for each iteration, and appending the generated datasets (possibly adding an identifier for each iteration) will produce a sample of datasets.
It might appear confusing that the command accepts variance inputs for the between-cluster heterogeneity and returns standard deviation estimates. In the meta-analysis literature, heterogeneity is usually defined using the variance, but, on the other hand, Stata models typically return standard deviations. We attempted to satisfy both practices.
When modelling continuous predictors (e.g., covariate or exposure), ipdpower generates them as standardised (mean=0, sd=1) to avoid potential complications due to the interaction term. However, in most cases users will wish to hypothesise effects for non-standardised variables plus it might not be straightforward to define mean levels for outcomes through b0(#) (e.g., P r(Y = 1|group = 0) for a binary outcome). To help researchers in setting up the correct design we have provided an accompanying Microsoft Excel file with examples across all possible exposure-covariate scenarios, with or without interaction effects (from http://www.statanalysis.co.uk/files/defining betas.xlsx). The command also returns aggregated simulation statistics with option di, allowing users to double-check the hypothesised coefficients and adjust if necessary.
When many random effects are modelled, assuming that all correlations between them are zero might not always be a realistic assumption. From a practical point of view, these correlations might have very small effects on performance while their hypothesised values for a particular study could be anyone's guess. Nevertheless, we have allowed relationships between normally distributed effects to be specified using a covariance matrix (option covmat(name)), and modelled with the drawnorm command. Such an approach was not possible when modelling non-normal random effects, however, and all correlations between non-normal effects are assumed to be zero.
ipdpower uses some of the mixed effects modelling commands that were renamed in Stata v13; xtmixed to mixed, xtmelogit to meqrlogit and xtmepoisson to meqrpoisson. However, we wished to ensure Stata v12 users would have access to the command and our choice does not affect users of later versions.
Future work could involve using ipdpower as a platform to inform on the effectiveness of multiple-imputation mechanisms, especially in Primary Care Databases under MNAR assumptions. In addition, although one-stage IPD meta-analysis is considered to be more robust from a theoretical perspective (Mathew and Nordstrom 2010) , the simplicity of a twostage IPD analysis and circumstantial evidence where results were very close with the two approaches make the latter appealing to researchers. However, the asymptotic nature of the methods implies that a theoretical comparison does not provide a complete picture and a simulation study is also needed to compare the two approaches, especially for small numbers of meta-analyses studies and in the presence of heterogeneity. Until such comparisons are made we must warn researchers that heterogeneity estimates in two-stage aggregate meta-analyses can be very inaccurate and more often than not seem to fail to account for existing heterogeneity (Kontopantelis and Reeves 2012; , and these methodological problems are likely to be an issue in two-stage IPD meta-analyses as well.
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